PGFC
ALXN

Peapack-Gladstone Financial Corp’s Alexion Pharmaceuticals ALXN Stock Holding History

Peapack-Gladstone Financial Corp’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,791
Closed -$249K – 326
2016
Q1 		$249K Sell
1,791
-150
-8% -$22K 0.02% 286
2015
Q4 		$370K Sell
1,941
-28
-1% -$4.89K 0.03% 237
2015
Q3 		$308K Hold
1,969
– – 0.02% 258
2015
Q2 		$356K Sell
1,969
-70
-3% -$12.1K 0.02% 247
2015
Q1 		$353K Buy
2,039
+416
+26% +$75.3K 0.02% 256
2014
Q4 		$300K Buy
1,623
+42
+3% +$7.78K 0.02% 260
2014
Q3 		$262K Buy
1,581
+90
+6% +$14.8K 0.02% 261
2014
Q2 		$233K Sell
1,491
-361
-19% -$57K 0.02% 276
2014
Q1 		$282K Sell
1,852
-321
-15% -$51K 0.02% 252
2013
Q4 		$289K Sell
2,173
-1,210
-36% -$145K 0.02% 243
2013
Q3 		$393K Hold
3,383
– – 0.03% 211
2013
Q2 		$312K Buy
+3,383
New +$326K 0.03% 230

Other funds holding ALXN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return